Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical)
Link
http://link.springer.com/content/pdf/10.1007/s40265-020-01432-7.pdf
Reference75 articles.
1. Evoy KE, Morrison M, Saklad SR. Pregabalin and gabapentin abuse: a systematic review. Drugs. 2017;77(4):403–26.
2. Peckham AM, Ananickal MJ, Sclar DA. Gabapentin use, abuse, and the US opioid epidemic: the case for reclassification as a controlled substance and the need for pharmacovigilance. Risk Manag Healthc Policy. 2018;11(1):109–16.
3. Schwan S, Sundström A, Stjernberg E, Hallberg E, Hallberg P. A signal for an abuse liability for pregabalin—results from the Swedish spontaneous adverse drug reaction reporting system. Eur J Clin Pharmacol. 2010;66(9):947–53.
4. Chiappini S, Schifano F. A decade of gabapentinoid misuse: an analysis of the European Medicines Agency’s ‘Suspected Adverse Drug Reactions’ database. CNS Drugs. 2016;30(7):647–54. https://doi.org/10.1007/s40263-016-0359-y.
5. Kapil V, Green JL, Le Lait MC, Wood DM, Dargan PI. Misuse of the c-aminobutyric acid analogues baclofen, gabapentin and pregabalin in the UK. Br J Clin Pharmacol. 2014;78(1):190–1.
Cited by 124 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Fatal pregabalin poisoning in Japan: A case report;Legal Medicine;2024-11
2. Risk of drug-related death associated with co-prescribing of gabapentinoids and Z-drugs among people receiving opioid-agonist treatment: A national retrospective cohort study;Psychiatry Research;2024-09
3. Prevalence and clinical outcomes of off‐label gabapentin prescription in neuropathic orofacial pain;Oral Surgery;2024-08-27
4. Assessing suicide risk in chronic pain management: a narrative review across drug classes;Expert Opinion on Drug Safety;2024-08-19
5. Association between gabapentin use and risk of dementia in adults with chronic pain: A nested case-control study;Journal of Affective Disorders;2024-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3